Exosomes are nanoscale extracellular vesicles released by cells and involved in intercellular communication. They carry proteins, lipids, RNA, DNA fragments, metabolites, and surface markers that can reflect the cell of origin and influence recipient cells. In biotechnology and nanomedicine, exosomes are studied both as natural information carriers and as potential diagnostic markers, therapeutic agents, and delivery vehicles.
Exosomes matter because they offer a biological nanoscale platform with relevance to cancer, immune regulation, neurodegeneration, cardiovascular disease, infection, regenerative medicine, and liquid biopsy. Their cargo and surface signatures can provide disease information, while engineered exosomes may deliver RNA, proteins, drugs, or gene-editing components. Key challenges include isolation, purification, characterization, heterogeneity, potency, targeting, storage, and scalable manufacturing. The topic connects closely to extracellular vesicles, nanomedicine, and RNA delivery.
Conferences on exosomes appear in biotechnology, nanomedicine, extracellular-vesicle research, diagnostics, oncology, regenerative medicine, and drug-delivery programs. Sessions often cover biomarkers, vesicle engineering, isolation methods, clinical translation, and therapeutic applications. Tracking exosome events helps researchers follow a fast-growing field where cell-derived nanoparticles are being developed for diagnosis and therapy.